# Octapharma Plasma, Inc. – FDA Inspection, Jul 24, 2012

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3a8cad01-cc76-4323-93db-4e04b2a26a1f
Source feed: FDA_Inspections

> FDA inspection 793025 of Octapharma Plasma, Inc., July 24, 2012. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 606 and 640. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 793025
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2012-07-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1259244 - 2024-12-13
- FDA Inspection 1047796 - 2018-03-01
- FDA Inspection 986379 - 2016-09-29
- FDA Inspection 913736 - 2015-02-10
- [FDA Inspection 897378 - 2014-09-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4b1c24e3-2d27-4c1c-a5e5-cd92bfa640d2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/3f87e0b7-6dca-4e6b-b727-0213f34cb9ac

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d